Discloseable transaction redemptions of wealth management product
Filed with HKEX · Stock code 314 · · 5 pages · English
Summary by 6ix AI
The company redeemed part of the product in two transactions, with the total accrued interest income from these redemptions amounting to a significant figure. The proceeds from these redemptions will be used for general working capital of the Group. The redemptions were made for treasury management purposes to maximize returns on surplus cash.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Sipai Health Technology Co., Ltd. on 6ix
Earlier from Sipai Health Technology
- Voluntary announcement - adoption of the 2026 share award scheme
- Further announcement on major transaction disposal of 100% equity interest in the target company and delay in despatch of circular
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2026
- Voluntary announcement acquisition of a 90% indirect equity interest in a licensed insurance broker company
- Major transaction disposal of 100% equity interest in the target company
Later from Sipai Health Technology
All Sipai Health Technology news releasesFollow Sipai Health Technology into a list and get an email when it puts out news.
Follow Sipai Health Technology